Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Colonic Neoplasms × encorafenib × Clear all

Phase

Status

Active not recruiting 4 Recruiting 2 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Melanoma 1 Colorectal Neoplasms 1 Colonic Neoplasms 1

Interventions

Oxaliplatin 7 Fluorouracil 4 tislelizumab 3 Irinotecan 3 raltitrexed 2 pembrolizumab 2 Leucovorin 2 Chemotherapy, Adjuvant 2 Capecitabine 2 zanidatamab 1 spartalizumab 1 sintilimab 1 rimegepant sulfate 1 encorafenib 1 cemiplimab 1 XELOX 1 X-Rays 1 Watchful Waiting 1 Surgical Procedures, Operative 1 Specimen Handling 1 Radioisotopes 1 Radiofrequency Ablation 1 Preoperative Exercise 1 Observation 1 Neoadjuvant Therapy 1 N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 1 Mortality 1 Magnetic Resonance Spectroscopy 1 Laparoscopy 1 Immune Checkpoint Inhibitors 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07178717 2025-09-17

REFISH

Vall d'Hebron Institute of Oncology

Phase 2 Not yet recruiting

Gastrointestinal

Colonic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡